Search

Search Constraints

You searched for: Author/Creator Layton, Mark

Search Results

2. A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Issue 2 (2nd February 2023)

3. Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. (October 2020)

5. Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study. (November 2020)

8. Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5. (June 2016)

10. Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network. (31st August 2017)